|
|
|
|
|
|
|
Evaluation of a New Multimodal Resin for Emerging Biotherapeutics
|
As biotherapeutics become more complex, purification scientists need flexibility for process optimization. This 15-minute on-demand webcast, Merck & Co., Inc., presents how Bio-Rad’s Nuvia™ wPrime 2A Media, a weak anion exchange and hydrophobic interaction chromatography (AEX-HIC) mixed-mode resin, provides a broad design space and improved yields while reducing aggregates and HCPs in comparison to existing monoclonal and bispecific antibody workflows. Watch now and request a sample.
|
|
|
|
FOCUS ON DOWNSTREAM MANUFACTURING
|
|
|
|
|
|
A conversation between Diana Colleluori at Biologics Consulting and Life Science Connect's Jon O'Connell
|
Regulators expect cell therapy manufacturers to prove they control for visible particles, but guidance remains notably quiet on the matter. Companies must get creative or risk clinical holds.
|
|
|
|
|
|
|
|
|
|
|
|
Analysis Of ADCs Using Hydrophobic Interaction Chromatography
|
|
Application Note | Agilent Technologies
|
Accurate DAR analysis in HIC requires systems that withstand corrosive salt conditions. Bioinert flow paths and baseline correction tools improve reproducibility, enabling confident characterization of ADCs.
|
|
|
|
|
|
|
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reducing The Bioburden Load In Drug Formulation And Filling
|
|
Application Note | By Critical Process Filtration, TCP Analytical
|
Sterile drug manufacturing requires preventing and removing contamination. Multi-stage filtration cuts microbial load, protects final filters, and supports quality, efficiency, and patient safety.
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|